Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia

Annals of Hematology

Volumn 90, Issue 5, 2011, Pages 515-521

  Lee, Yun Gyoo ^a   Kim, Inho ^a,b   Kim, Jin Hee ^b   Bae, Ji Yeon ^b   Kwon, Ji Hyun ^a   Shin, Dong Yeop ^a   Lee, Jong Eun ^c   Song, Eun Young ^a   Kim, Hyun Kyoung ^a   Yoon, Sung Soo ^a,b   Park, Sung Sup ^a   Lee, Dong Soon ^a   Han, Kyou Sup ^a   Park, Myoung Hee ^a   Hong, Yun Chul ^b   Park, Seonyang ^a,b   Kim, Byoung Kook ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c DNA Link Inc   (South Korea)

Author keywords

Aplastic anemia; Cytokine; Immunosuppressive therapy; Polymorphism

Indexed keywords

CYCLOSPORIN; FAS ANTIGEN; GAMMA INTERFERON; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ADULT; ALLELE; APLASTIC ANEMIA; ARTICLE; CONTROLLED STUDY; DOMINANT GENE; FAS GENE; FEMALE; GAMMA INTERFERON GENE; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECESSIVE GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFORMING GROWTH FACTOR BETA GENE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; ALLELES; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; FEMALE; GENES, DOMINANT; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79956151627     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-010-1102-2     Document Type: Article

References (24)

1. Young N, Calado R, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:2509
2. Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A (2000) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 95:1931-1934
3. Fuhrer M, Rampf U, Baumann I, Faldum A, Niemeyer C, Janka-Schaub G, Friedrich W, Ebell W, Borkhardt A, Bender-Goetze C (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 106:2102-2104 (Pubitemid 41291726)
4. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Fuhrer M (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood to Marrow Transplantation (EBMT). Haematologica 92:11-18 (Pubitemid 46232653)
5. Dufour C, Corcione A, Svahn J, Haupt R, Battilana N, Pistoia V (2001) Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. Br J Haematol 115:1023-1031 (Pubitemid 34042928)
6. Sloand E, Kim S, Maciejewski JP, Tisdale J, Follmann D, Young NS (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 100:1185-1191 (Pubitemid 34864270)
7. Maciejewski J, Selleri C, Anderson S, Young NS (1995) Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183-3190
8. Killick SB, Cox CV, Marsh JC, Gordon-Smith EC, Gibson FM (2000) Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol 111:1164-1169 (Pubitemid 32104934)
9. Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134:392-404
10. Rizzo S, Killick SB, Patel S, Ball SE, Wadhwa M, Dilger P, Gordon-Smith EC, Gibson FM (1999) Reduced TGF-beta1 in patients with aplastic anaemia in vivo and in vitro. Br J Haematol 107:797-803 (Pubitemid 30020153)
11. Dufour C, Capasso M, Svahn J, Marrone A, Haupt R, Bacigalupo A, Giordani L, Longoni D, Pillon M, Pistorio A, Di Michele P, Iori AP, Pongiglione C, LanciottiM, IolasconA (2004)Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematol 126:682-685 (Pubitemid 39221303)
12. Gidvani V, Ramkissoon S, Sloand EM, Young NS (2007) Cytokine gene polymorphisms in acquired bone marrow failure. Am J Hematol 82:721-724 (Pubitemid 47221653)
13. Peng J, Liu C, Zhu K, Zhu Y, Yu Y, Li J, Hou M, Chen X, Xu C, Zhang M (2003) The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR. Hum Immunol 64:896-901 (Pubitemid 37093462)
14. Demeter J, Messer G, Schrezenmeier H (2002) Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia. Ann Hematol 81:566-569 (Pubitemid 36097041)
15. Takaku T, Calado RT, Kajigaya S, Young NS (2009) Interleukin-23 receptor (IL-23R) gene polymorphisms in acquired aplastic anemia. Ann Hematol 88:653-657
16. Anonymous (1987) Incidence of aplastic anemia: the relevance of diagnostic criteria. By the international agranulocytosis and aplastic anemia study. Blood 70:1718-1721
17. Camitta B, Thomas E, Nathan D, Santos G, Gordon-Smith E, Gale R, Rappeport J, Storb R (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63
18. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint M, Congiu M, De Planque M, Ernst P, McCann S (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party. Br J Haematol 70:177-182
19. Camitta BM (2000) What is the definition of cure for aplastic anemia? Acta Haematol 103:16-18
20. Scheinberg P, Wu CO, Nunez O, Young NS (2009) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144:206-216
21. Nistico A, Young NS (1994) Gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120:463-469 (Pubitemid 24075223)
22. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26:1-3
23. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863-866
24. Fermo E, Bianchi P, Barcellini W, Pedotti P, Boschetti C, Alfinito F, Cortelezzi A, Zanella A (2004) Immunoregulatory cytokine polymorphisms in Italian patients affected by paroxysmal nocturnal haemoglobinuria and aplastic anaemia. Eur J Immunogenet 31:267-269 (Pubitemid 39572285)